PREVALENCE OF ANTI-CN1A ANTIBODIES AND ITS CLINICAL SIGNIFICANCE - A RETROSPECTIVE MONOCENTRIC STUDY

被引:0
|
作者
Silva, S. P. [1 ,2 ]
Fortes, C. [2 ,3 ]
Eugenio, G. [1 ,2 ]
Barcelos, A. [1 ,2 ,4 ]
机构
[1] Ctr Hosp Baixo Vouga, Rheumatol Dept, Aveiro, Portugal
[2] Egas Moniz Hlth Alliance Acad Clin Ctr, Aveiro, Portugal
[3] Ctr Hosp Baixo Vouga, Clin Pathol, Aveiro, Portugal
[4] Nova Med Sch, Comprehens Hlth Res Ctr, Lisbon, Portugal
关键词
Descriptive studies; Autoantibodies; Epidemiology;
D O I
10.1136/annrheumdis-2023-eular.5959
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB1539
引用
收藏
页码:2002 / 2003
页数:2
相关论文
共 50 条
  • [11] The utility of anti-cN1A autoantibody for the diagnosis of sporadic inclusion body myositis
    Nihimura, H.
    Suzuki, S.
    Noguchi, S.
    Uruha, A.
    Mitsuhashi, S.
    Hayashi, Y. K.
    Nonaka, I.
    Nishino, I.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 815 - 815
  • [12] Clinical significance of ANCA positivity in patients with IgA vasculitis: a retrospective monocentric study
    Kim, Jae Yeon
    Choi, Hyeok
    Kim, Minyoung Kevin
    Lee, Soo Bin
    Park, Yong-Beom
    Lee, Sang-Won
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (11) : 1927 - 1936
  • [13] Clinical significance of ANCA positivity in patients with IgA vasculitis: a retrospective monocentric study
    Jae Yeon Kim
    Hyeok Choi
    Minyoung Kevin Kim
    Soo Bin Lee
    Yong-Beom Park
    Sang-Won Lee
    Rheumatology International, 2019, 39 : 1927 - 1936
  • [14] Pathogenic role of anti-cN1A autoantibodies in sporadic inclusion body myositis
    Yamashita, Satoshi
    Tawara, Nozomu
    Zhang, Ziwei
    Nakane, Shunya
    Sugie, Kazuma
    Suzuki, Naoki
    Nishino, Ichizo
    Aoki, Masashi
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2023, 94 (12): : 1018 - 1024
  • [15] Anti-SSA52 antibodies - A retrospective study on clinical significance from a tertiary hospital
    Queiroz, C.
    Maresch, A.
    Monteiro, R.
    Cunha, R.
    Mendes, A.
    Rodrigues, F.
    CLINICA CHIMICA ACTA, 2019, 493 : S89 - S89
  • [16] The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis
    Asano, Y
    Ihn, H
    Yamane, K
    Kubo, M
    Yazawe, N
    Fujimoto, M
    Tamaki, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) : 551 - 551
  • [17] Antigen Bead Array versus ELISA to Detect anti-cN1A Antibodies in Patients with Sporadic Inclusion Body Myositis and Correlation with Clinical, Serological and Histological Features
    Notarnicola, Antonella
    Bonomi, Francesco
    Hellstrom, Cecilia
    Pin, Elisa
    Idborg, Helena
    Nilsson, Peter
    Lundberg, Ingrid E.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [18] The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis
    Asano, Y
    Ihn, H
    Yamane, K
    Kubo, M
    Tamaki, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (02) : 204 - 210
  • [19] Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients
    Roussel, V
    Yi, F
    Jauberteau, MO
    Couderq, C
    Lacombe, C
    Michelet, V
    Gil, R
    Couratier, P
    Vallat, JM
    Preud'homme, JL
    JOURNAL OF AUTOIMMUNITY, 2000, 14 (03) : 259 - 265
  • [20] IN MYOSITIS PATIENTS, SJOGREN'S SYNDROME IS ASSOCIATED WITH INCLUSION BODY MYOSITIS AND WITH ANTI-CN1A ANTIBODIES INDEPENDENTLY OF THE MYOSITIS SUBTYPE
    Levy, D.
    Nespola, B.
    Giannini, M.
    Felten, R.
    Varoquier, C.
    Rinagel, M.
    Korganow, A. S.
    Poindron, V.
    Martin, T.
    Maurier, F.
    Chereih, H.
    Bouldoires, B.
    Hervier, B.
    Lenormand, C.
    Arnaud, L.
    Geny, B.
    Sibilia, J.
    Gottenberg, J. E.
    Meyer, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 704 - 705